











Title of Document: AN EXPERIMENTAL INVESTIGATION OF 
THE FUNCTIONAL RELATIONSHIP 
BETWEEN SOCIAL PHOBIA AND 
CIGARETTE SMOKING 
  
 Jennifer Renee Dahne, Master of Science, 2013  
  




Individuals with Social Phobia (SP) represent a large group with elevated rates of 
cigarette smoking and cessation rates lower than that of individuals without 
psychopathology. For individuals with SP, cigarette smoking may be used to reduce 
social anxiety in anticipation of and during social situations, however, no study to 
date has experimentally examined this function. The aim of the current study was to 
experimentally examine the functional relationship between cigarette smoking and SP 
as a function of induced social stress. Results indicated that high SP individuals 
experienced significant decreases in negative affect following smoking a cigarette 
when experiencing social stress. This effect was specific to high SP individuals under 
social stress condition and was not observed among individuals average in SP or 
when examining changes in positive affect. Findings are discussed in the context of 
understanding risk factors for smoking initiation and maintenance as well the 
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Chapter 1: Introduction 
Cigarette Smoking 
 Cigarette smoking is the leading cause of death and disability in the United 
States, estimated to kill 443,000 people in the United States annually (CDC, 2008a). 
Smoking-related illness costs an estimated $96 billion in medical costs and $97 
billion in lost productivity each year (CDC, 2008a). Further, for every individual who 
dies from a smoking-attributable cause, another 20 currently live with a serious 
smoking-related disease (CDC, 2008a). While recent efforts have focused on 
prevention as well as creating effective smoking cessation programs, one in five U.S. 
high school students and adults still smoke cigarettes (CDC, 2008b, 2009). 
Smoking and psychological comorbidity 
 Of the 443,000 individuals who die annually due to smoking-related causes in 
the United States, individuals with psychological disorders account for 200,000 of 
these deaths, or approximately 45% (CDC, 2008a). In contrast, prevalence estimates 
suggest that 20% of adults in the U.S. are affected by psychological disorders during 
a given year (USDHHS, 1999). Thus, among smokers, the percentage of these 
individuals with psychopathology is higher than expected from the general 
population. Individuals with both past month and lifetime psychopathology quit 
smoking at rates lower than individuals without a history of psychopathology (Lasser 
et al., 2000). Further, this population of individuals with psychological disorders 
consumes 44% of cigarettes each year, making them an important target for 




Psychological comorbidities that may have a functional relationship with 
smoking, or those in which smoking may be used as a tool to cope with the disorder 
or manage symptoms of the disorder, may be of the greatest concern. Social Phobia 
(SP) is one disorder that may have a functional relationship with cigarette smoking. 
12.1% of the U.S. population meets criteria for SP at some point in their life (Ruscio 
et al., 2008). Further, there are significantly greater rates of smoking among 
individuals with SP than among individuals without psychological comorbidities with 
54.0% of individuals with SP being lifetime smokers and 35.9% of individuals with 
SP being current smokers (Lasser et al., 2000; Ruscio et al., 2008). Thus, 38 million 
people in the U.S. meet criteria for SP at some point in their lives and 20.5 million of 
these individuals are lifetime smokers, while 13.5 million are current smokers. 
Moreover, although 33.4% of individuals with SP successfully quit smoking, this is a 
percentage significantly lower than that of individuals without comorbid 
psychopathology (42.5%) (Lasser et al., 2000).  
These data indicate that rates of smoking among individuals with SP are 
elevated and these individuals quit smoking at lower rates than individuals without 
concomitant psychopathology, but there is a need for targeted work examining the 
functional relationship between smoking and SP to better understand the nature of 
this comorbidity. In that vein, I will next present an overview of SP and then turn to 





Definition and prevalence 
SP, also known as social anxiety disorder (SAD), is a disorder characterized 
by anxiety in situations involving potential interaction or scrutiny by others (such as 
while speaking, eating, or writing) (APA, 2000; Beidel, Rao, Scharfstein, Wong, & 
Alfano, 2010). Hallmarks of SP include low positive affect and behavioral inhibition, 
as well as difficulties with social discourse, few social relationships, and limited 
occupational range with occupational choice based on expectancy of social 
interaction (Beidel et al., 2010; Bruch, Fallon, & Heimberg, 2003). Along these lines, 
areas of associated functional impairment for individuals with SP cut across multiple 
domains including occupational, academic, and social impairments. 
SP is the most common anxiety disorder and is one of the most prevalent 
psychological disorders, with the National Comorbidity Survey (NCS) replication 
indicating that lifetime prevalence of SP was surpassed only by major depressive 
disorder, alcohol abuse, and specific phobia (Kessler et al., 2005). Recent incidence 
rate estimates by Grant and colleagues (2008) suggest that the one-year incidence of 
SP is 0.32. Prevalence estimates for past year and lifetime SP are approximately 7.1% 
and 12.1% respectively (Kessler et al., 2005; Ruscio et al., 2008). SP exhibits 
substantial comorbidity with other mental health problems such as other anxiety 
disorders, mood disorders, impulse control disorders, and substance use disorders 
(Kessler et al., 2005; Mineka, Watson, & Clark, 1998; Ruscio et al., 2008). Research 
suggests that SP has an earlier onset than many other disorders, with the average age 
of onset between 13 and 15 years of age, though SP has been found in children as 




adulthood, particularly without treatment and with an earlier age of onset (before the 
age of 11) (Ballenger et al., 1998; Chartier, Walker, & Stein, 2003).  
Coping with Social Phobia through Cigarette Smoking 
While approximately 21% of the US population smokes cigarettes, prevalence 
estimates of cigarette smoking in individuals with SP have been as high as 35.9% 
(Baker-Morissette, Gulliver, Wiegel, & Barlow, 2004; Dube, McClave, Caraballo, 
Kaufmann, & Pechacek, 2010; Himle, Thyer, & Fischer, 1988; Lasser et al., 2000; 
McCabe et al., 2004). In a sample of German adolescents and young adults, 5.1% of 
nicotine dependent smokers also met criteria for SP, whereas 2.3% of non-nicotine 
dependent smokers met criteria for SP and 1.9% of non-smokers met criteria for SP, 
with nicotine dependence defined using DSM-IV criteria (Nelson & Wittchen, 2000). 
It is important to note that these differences were not statistically significant, likely 
because this study did not specifically recruit and examine individuals with SP, thus 
the number of individuals with SP was small. Nonetheless, these results suggest that a 
relationship exists between SP and cigarette smoking, with smokers being more likely 
to meet criteria for SP. In a more recent study using a community sample of 
adolescents, a SP diagnosis was significantly associated with cigarette smoking for 
boys, but not for girls (Wu et al., 2010), an interesting finding considering that SP is 
equally prevalent in males and females (Grant et al., 2008).  
Given the heightened symptoms of anxiety associated with social situations 
present in SP, individuals with SP may attempt to cope with this affective distress 
through cigarette smoking. This argument is supported by findings that regular 




rates of smoking among individuals with SP is attributable to SP leading to cigarette 
smoking (Johnson et al., 2000). Considering the anxiolytic properties of nicotine, 
cigarette smoking may be a particularly relevant strategy for regulating anxiety tied to 
social fears for individuals with SP (Kassel & Unrod, 2000; Pomerleau, Turk, & 
Fertig, 1984). While cigarette smoking may be used as an anxiolytic to reduce 
feelings of distress in social situations, it has also been proposed that for individuals 
with SP, cigarette smoking may aid in increasing social contact with other smokers 
(McCabe et al., 2004; Wittchen, Stein, & Kessler, 1999). Considering the long-term, 
well-known health consequences of continued cigarette smoking, placing smoking as 
the leading cause of death and disability in the United States, this relationship 
between SP and cigarette smoking warrants investigation (USDHHS, 2004). 
Two longitudinal studies exist that suggest that SP, as well as sub-threshold 
symptoms of SP (having at least one social fear), are related to the onset of nicotine 
dependence. Breslau, Novak, & Kessler (2004) examined the role of DSM-III-R 
psychiatric disorders in predicting the subsequent onset of daily smoking, smokers’ 
progression to nicotine dependence, and the persistence of smoking by using the 
Tobacco Supplement of the NCS. Breslau and colleagues (2004) found that 
individuals with any history of SP (either current or past) were 1.5 times more likely 
to be daily smokers than individuals without a history of SP (OR: 1.5 (1.2-1.7)). 
Furthermore, individuals with past SP (but not active) were 2.8 times more likely to 
be daily smokers than individuals without past SP (OR: 2.8 (1.4-5.4)) and individuals 




without active SP (OR: 1.3 (1.1-1.6)). Thus, current as well as past SP placed 
individuals at a heightened risk of becoming regular cigarette smokers.  
 Second, another prospective, longitudinal study addressed the relationship 
between nicotine dependence and SP. Sonntag and colleagues (2000) investigated 
associations between SP and smoking behavior in a community sample of adolescents 
and young adults (age 14-24 at baseline) to explore whether SP predicts the first onset 
of cigarette smoking, regular smoking and the development of nicotine dependence. 
This study also examined the relationship between sub-threshold SP (having at least 
one social fear, but not meeting criteria for SP) and cigarette smoking. At baseline, 
among dependent regular smokers, 15.4% reported no social fears, 26.1% reported 
social fears, but did not meet criteria for SP, and 31.5% met criteria for SP. At the 4-
year follow-up, individuals who were non-smokers or non-dependent smokers at 
baseline, but endorsed at least one social fear, had an increased risk of meeting 
criteria for nicotine dependence at the follow-up. Similar patterns emerged for 
occasional users and non-dependent regular smokers with social fears, but who did 
not have a SP diagnosis as well as for occasional users with a SP diagnosis, but these 
patterns did not reach statistical significance. Taken together with the study by 
Breslau and colleagues, these findings remain inconclusive but suggest that a 
relationship exists between SP and smoking and that SP, as well as sub-threshold SP, 
may predict the onset of nicotine dependence and that this relationship is evident 
across developmental periods. Although these studies provide evidence for a temporal 
relationship between SP and cigarette smoking, they do not test specific mechanisms 




in understanding whether there is a particular function of cigarette smoking for those 
with SP. I next move to consideration of negative reinforcement as a framework 
through which cigarette smoking may serve a functional role for individuals with SP. 
Negative Reinforcement Framework 
In teasing apart potential mechanisms for the relationship between cigarette 
smoking and SP, a negative reinforcement model offers a relevant framework. 
Negative reinforcement models suggest that the motivational basis of addictive drug 
use is the reduction or avoidance of aversive internal states (Baker, Piper, McCarthy, 
Majeskie, & Fiore, 2004). These aversive internal states may be related to withdrawal 
from nicotine, but may also be related to more general negative affect (NA). From a 
negative reinforcement framework, individuals with SP would smoke cigarettes in 
order to reduce or avoid feelings of distress in relation to social situations or in 
anticipation of social situations. There has been some support for this negative 
reinforcement link between SP and cigarette smoking in early adolescence prior to the 
onset of regular smoking such that adolescents high in SP report greater urge to 
smoke during peer interactions than adolescents without elevated SP symptoms 
(Henry, Jamner, & Whalen, 2012).  
The relationship between NA and smoking outside of the context of SP has 
been well documented (Kassel, Stroud, & Paronis, 2003) and this relationship may be 
particularly important for individuals with SP who experience heightened NA in 
anticipation of and during social situations. Across studies, cigarette smokers have 
been found to exhibit trait characteristics that may confer a predisposition for higher 




et al., 2010; Welch & Poulton, 2009). In turn, these enduring personality 
characteristics may predispose a person to look for a source of affective control, such 
as cigarette smoking. Along these lines, as reviewed by Kassel and colleagues (2003), 
numerous studies have indicated that cigarette smokers cite NA control as a primary 
motivation for smoking cigarettes. For individuals with SP, this suggests that 
reducing NA broadly and social anxiety specifically may be an important 
consequence of smoking cigarettes. Interestingly, while smoking a cigarette has been 
found to relieve the acute effects of nicotine withdrawal, one form of NA-motivated 
smoking, findings relating to the relief of other forms of NA such as environmental 
stressors have been less clear. For instance, Perkins and colleagues (2010) found that 
smoking a cigarette reliably reduced NA following a period of abstinence, but less 
robust decreases in NA were seen following other NA inducing procedures such as a 
computer memory challenge task and having to give a speech in front of observers. 
However, other studies have found that stress manipulations increase cigarette 
craving (e.g., Buchmann et al., 2010; Childs & de Wit, 2010). Thus, while control of 
NA is widely reported as a primary motive for smoking cigarettes, this regulation of 
negative affect may be specific to certain forms of stressors. Further, this line of 
research has yet to be extended to individuals with SP or with elevated SP symptoms, 
a population for which NA may be a primary motive for smoking and reason why 
cigarette smoking is maintained over time.   
Summary and Significance 
Cigarette smoking is a prevalent, deadly, and costly behavior for which 




smoking are particularly elevated among individuals with psychopathology. Within 
this category of individuals with psychopathology, individuals with SP represent a 
large group with elevated rates of cigarette smoking who quit smoking at rates lower 
than that of individuals without psychopathology. These findings highlight cigarette 
smokers with SP as a particularly important group for further examination.  
 A negative reinforcement framework would suggest a link between SP and 
cigarette smoking. While little research exists examining the functional relationship 
between SP and cigarette smoking, negative reinforcement models of cigarette 
smoking suggest that a functional relationship would exist between SP and cigarette 
smoking. Moreover, negative reinforcement models of cigarette smoking suggest that 
the motivational basis of addictive drug use is the reduction or avoidance of aversive 
internal states. This process is particularly relevant for SP considering increased 
feelings of anxiety in response to social situations and the need to regulate this 
anxiety. Along these lines, control of NA by smoking cigarettes may be a reason why 
individuals with SP initiate tobacco use and maintain use over time.  
Despite knowledge of a temporal relationship between SP and cigarette 
smoking and the presence of strong theory to suggest a functional relationship, 
research provides little guidance to determine if cigarettes are being used to regulate 
NA and reduce anxiety by individuals with SP in the context of social stress. 
Considering the long-term consequences of cigarette smoking, it is important to get a 
clear understanding of the functional relationship between cigarette smoking and SP 
in order to create targeted interventions and cessation programs in the future for 






The primary aims of the current study are to examine the relationship between 
level of SP (high SP, healthy control with average SP) and cigarette smoking-related 
outcomes (smoking topography) as well as to examine the relationship between level 
of SP and NA as a function of induced social stress (neutral, stress). To address these 
questions, participants were recruited based on regular cigarette smoking and their 
level of SP and were categorized into either a high or average SP group. Participants 
were specifically screened to form the high SP and healthy control with average SP 
groups using a SP screening measure. If eligible for the study, participants attended 
two experimental sessions, one a neutral condition and the other a social stressor 
condition, with session order counterbalanced across participants. The social stressor 
involved participants expecting that they would be required to deliver a speech to a 
panel of judges who would judge their performance. After being told they would be 
giving a speech, but before actually giving the speech, smoking topography data was 
collected and participants completed a measure of affect. Participants self-reported 
NA and positive affect (PA) three times during each experimental session in order to 
assess changes in affect associated with condition and cigarette smoking. To our 
knowledge, this is the first experimental study to examine the relationship between 
SP and cigarette smoking. We propose: 
Aim 1: To examine group differences (high SP, average SP) in smoking outcomes in 
response to two conditions (neutral, induced social stress) among individuals who 




Hypothesis: In response to a social stressor, smokers who are high in SP, 
compared to individuals who are average in SP, will have greater smoking 
outcomes evidenced by greater puff number, greater puff volume, and shorter 
interpuff interval during smoking topography measures. This difference will 
be evident within the high SP group compared to a neutral condition and 
between groups in the stressor condition, with no differences between groups 
in the neutral condition.  
Aim 2: To examine group differences (high SP, average SP) in NA in response to two 
conditions (neutral, induced social stress) as a function of cigarette smoking among 
individuals who smoke cigarettes.  
Hypothesis: The relationship between SP group and affect will vary as a 
function of condition. Individuals who are high in SP, compared to individuals 
who are average in SP, will exhibit significantly greater increases in NA in 
anticipation of a social stressor followed by significantly greater decreases in 









Chapter 2: Research Design and Methods 
Overall Design 
A 2 x 2 mixed factorial design was used to examine changes in smoking 
topography outcomes (number of puffs, average volume, total volume, interpuff 
interval) and affect. For examining changes in smoking topography, condition (2; 
neutral, social stress) was the within-subject factor and SP level (high SP, average 
SP) was the between-subjects factor. For examining changes in affect, PANAS 
administration (3 administrations) was the within-subject factor and SP level (high 
SP, average SP) was the between-subjects factor. To explicate presentation of results, 
a data analytic plan for addressing these study aims is integrated within Chapter 3: 
Results.  
Participants 
Participants were recruited from the University of Maryland, College Park 
campus using flyers and postings on internet message boards and websites (e.g., 
campus listservs, Craigslist, Facebook). Half of the recruitment materials announced 
a study for cigarette smokers, while the other half of recruitment materials advertised 
a study for shy cigarette smokers. Interested individuals were advised to contact the 
study by phone or e-mail to complete an online screening to determine eligibility.  
During the online screening, participants were asked demographic and 
psychiatric questions to determine their eligibility for the study. To be included in the 
study, participants had to report being current regular smokers between the ages of 18 




for the past 6 months, (2) smoked 20 or more days out of the last 30 days, and (3) 
scored either above a 35 on the Social Interaction Anxiety Scale (SIAS; Mattick & 
Clarke, 1998) comprising the high SP group, or between a 9 and a 24 on the SIAS 
comprising the average SP group. The SIAS cutoff values are taken from the initial 
validation study of the scale in which Mattick and Clarke (1998) found that 
individuals with SP had a mean of 34.6 with a standard deviation of 16.4 on the SIAS 
and that undergraduate students had a mean of 19.4 with a standard deviation of 10.1. 
Thus, in the present study, to categorize between high and average SP groups, the 
high SP group was at or above the SP sample mean (above 35) and the average SP 
group was within 1 standard deviation below and 0.5 standard deviations above the 
undergraduate mean (9-24). The undergraduate norm was chosen rather than the 
community sample because the undergraduate sample is closest in age (mean age = 
21.6 as compared to 32.2 for the community sample) to the targeted sample for the 
present study. 
Measures 
Measures assessed four domains including: 1) Smoking history and current 
smoking information, 2) Social phobia, 3) Affect, and 4) Smoking outcomes. Each 
measure is described in detail below. 
Smoking History and Current Smoking Information 
1.     NCI Smoking History and Current Status Indices (Shumaker & Grunberg, 




status indices agreed upon by a NCI consensus panel (1986) including: rate, 
brand, nicotine content, previous quit attempts and duration, and onset age.  
2.     Modified Fagerstrom Tolerance Questionnaire (mFTQ, Prokhorov et al., 
2000). Nicotine dependence was assessed using a modified version of the 
Fagerstrom tolerance questionnaire (mFTQ), which was developed 
specifically for adolescent smokers (Prokhorov et al., 2000). Previous 
research has demonstrated that this measure is valid and applicable to 
adolescent smokers (Kassel et al., 2007; Prokhorov et al., 2000). 
3.     Timeline Followback (Brown et al., 1998). Timeline Followback (TLFB) 
procedures were used to index number of cigarettes smoked. The TLFB 
procedure has good reliability and validity with adolescent (Lewis-Esquerre 
et al., 2005) and adult smokers (Brown et al., 1998). At session 1, TLFB 
information was collected for the past 30 days and at session 2, TLFB 
information was collected for the interim period since session 1.  
Social Phobia 
1.     Social Interaction Anxiety Scale (SIAS; Mattick & Clarke, 1998). The 
SIAS is a 20-item measure designed to measure anxiety in response to 
situations involving interaction with others using a 5-point scale, ranging 
from 0 to 4 (e.g., not at all characteristic or true of me to extremely 
characteristic or true of me). The statements reflect the level of general 
anxiety associated with the initiation and maintenance of social interactions 




sex). During initial validation, the SIAS was found to discriminate between 
individuals with SP and community subjects. In the present study, the SIAS 
was used as a screening and grouping measure to categorize participants 
based on SP level into one of two groups: high SP or average SP. 
Affect 
1.     Positive and Negative Affect Scale (PANAS; Watson et al., 1988). The 
PANAS is a commonly used 20-item mood measure that assesses two 
global dimensions of affect: negative and positive. A large body of 
literature supports the validity of the PANAS (Watson, 2000). The scale 
assesses both positive affect (PA) and negative (NA) affect. PA reflects the 
extent to which a person feels enthusiastic, alert, and active while NA 
reflects a person’s subjective distress and encompasses anger, contempt, 
disgust, and guilt. The PANAS commonly is used to detect changes in 
emotional reactions to stimuli in the manner proposed here and has been 
found to have good internal consistency (Cronbach’s alpha = .86-.90 for 
PA, .84-.87 for NA; Crawford & Henry, 2004) and good construct, 
convergent and discriminant validity in clinical and non-clinical samples 
(Watson et al., 1988).  The NA score was calculated by taking the sum of 
ratings for the 10 NA items. Likewise, the PA score was calculated by 
taking the average of ratings for the 10 PA items. The measure was 





1.     Smoking Topography (Hammond et al., 2005). CReSSmicro (Plowshare 
Technologies, Inc., Baltimore, MD) is a battery-operated portable device 
that measures a host of smoking topography variables (puff volume, puff 
number, puff duration, average flow, interpuff interval, time, and date). The 
device is small (2.5 x 2.2 x 1.2 inch, 3.1 oz), allowing independent use in 
the participant’s natural environment. CReSSmicro uses an orifice flow 
meter mouthpiece to determine flow rate. All of the smoking topography 
variables are derived from the basic measurements of flow and time. 
Participants were allowed to smoke cigarettes through the CReSSmicro 
before and after the experimental manipulation in order to assess changes in 
smoking behavior between experimental sessions. From the basic 
topography measurements, we calculated four key variables of interest: 1) 
average volume, 2) total volume, 3) number of puffs, and 4) interpuff 
interval. 
Assessment Procedures 
The study consisted of two sessions held at the Center for Addictions, 
Personality and Emotion Research at the University of Maryland College Park. All 






The online screening included questions about smoking behavior. Participants 
completed the SIAS (Mattick & Clarke, 1998) within the online screening. 
Demographic information such as date of birth, gender, ethnicity/race, marital status, 
and years of education were collected and re-confirmed at Session 1. If eligible for 
the study, participants were contacted via email or phone for scheduling and asked to 
bring at least two cigarettes of their preferred brand to each of the experimental 
sessions. 
Experimental Sessions 
Condition order was counterbalanced (neutral first or social stress first) and, 
with the exception of video content, the sessions followed identical procedures. 
Participants completed consent procedures at the beginning of their first experimental 
session. Following consent (during the first session) or at the beginning of the second 
session, participants were escorted outside and given the option to smoke a cigarette 
through the CReSSmicro smoking topography mouthpiece. The purpose of smoking 
this cigarette at the beginning of each session was to control for time since last 
cigarette smoked and to allow participants to acclimate to the topography mouthpiece. 
Participants then completed self-report measures (Smoking history or mFTQ, 
PANAS) in a separate room. During session 1, participants completed the TLFB for 
cigarettes smoked in the past month while, during session 2, participants completed 
the TLFB for the time between sessions 1 and 2. Because the mFTQ and NCI 
smoking history and current status indices are stable and not time sensitive, they were 




Following measure completion, participants watched a control video (nature 
video) or a social stressor video (a variant of the Trier Social Stress task (TSST) 
video). In the TSST video, participants were told that they would be giving a speech 
to a panel of judges who would judge the quality of their speech. Participants then 
completed the PANAS (administration 2). Next, participants were again escorted 
outside and given the option to smoke a cigarette through the CReSSmicro smoking 
topography mouthpiece. After smoking this second cigarette, participants again 
completed the PANAS (administration 3). At the end of the session, participants were 
debriefed and compensated for participation. For a schedule of the administration of 
measures, see Table i below. 
 




Chapter 3: Results 
Descriptive Findings 
Participants 
413 individuals completed the initial screening. Of these 413, 104 were 
eligible for the study (25.2%). Individuals who completed the screening, but who 
were not eligible, were ineligible due to their current smoking levels (n=140), SIAS 
scores (n=154), age (n=120), or due to deceitful/misleading responses on the 
screening (n=9). Of the 104 eligible, 73 participants (41.7% female, Age M(SD) = 
19.75(1.18), n = 31 High SP) attended at least one of the experimental sessions. Two 
participants in the Average SP group did not attend a second experimental session 
and were not included in subsequent analyses. Participants were excluded from 
subsequent repeated measures ANOVA analyses due to missing or incomplete 
smoking topography data (n=14) or PANAS data (n=4). Reasons for missing or 
incomplete topography data included device malfunctions and participants choosing 
to smoke cigarettes that did not properly fit into the topography devices. Patterns of 
missing data did not significantly differ between SP groups. See Table ii for 
information regarding sample demographics. 
Cigarette Smoking 
Average cigarettes per smoking day (CPSD) was obtained via the TLFB by 
dividing the total number of cigarettes smoked in the last month by the total number 
of days on which the participant smoked in the last month. Average CPSD for the 




15.83(2.45), began smoking weekly at age 17.57(1.54), and began smoking daily at 
age 18.28(1.31). Regarding nicotine dependence, levels were relatively low with 
3.90(1.41) as the mean score on the mFTQ. High SP individuals (M(SD)=8.95(5.39)) 
reported on average smoking significantly more CPSD than low SP 
(M(SD)=6.29(3.83)) individuals (t(70)=-2.46, p=.04). 
Puff Topography 
Across the two experimental sessions, participants smoked up to four 
cigarettes (one in each session prior to video presentation (Cigarette 1) and one 
following video presentation (Cigarette 2)). The vast majority of participants decided 
to smoke each cigarette they were given the option to smoke ( > 91.7%; for the 
number of participants who chose to smoke each cigarette, see Table iii). Four 
topography variables of interest were calculated from the puff topography data: 1) 
Total number of puffs for each cigarette, 2) Mean puff volume, defined as the average 
volume of all measured puffs, 3) Total puff volume, defined as the sum of all 
measured puff volumes, and 4) Mean interpuff interval (IPI), defined as the average 
amount of time between measured puffs. Greater tobacco self-administration would 
be indicated by more puffs, higher mean puff volume, higher total puff volume, and 
shorter IPI. Topography data for each cigarette is presented in Table iv below. There 







PA and NA items on the PANAS were summed to create PA and NA scores 
for each individual for each administration of the PANAS. Descriptive statistics for 
PA and NA can be found in Table v. 
Data Analytic Plan and Data Analyses to Address Primary Study Aims 
In order to address the study aims, we followed several data analytic steps 
which are each described in detail below. First, using repeated measures ANOVAs, 
we explored the impact of demographic variables (age, race/ethnicity, gender) and 
CPSD on the dependent variables of interest (NA, PA, topography variables). After 
determining covariates to be included in analyses to address the primary study aims, 
we used repeated measures ANOVA analyses to examine within and between group 
(High vs. Average SP) differences in the dependent variables of interest (smoking 
topography, NA, PA) as a function of condition (Neutral vs. Social Stress). Each 
analysis with corresponding results is described in detail below beginning with 
analyses to determine the inclusion of potential covariates and then moving to 
analyses to address each of the primary study aims.      
Determining covariates in subsequent analyses 
To determine whether demographic variables (age, race/ethnicity, gender) and 
CPSD should be included as covariates in subsequent analyses, we conducted several 
repeated measures ANOVAs (one per dependent variable) to examine the impact of 
each potential covariate (4 total) on each dependent variable of interest (4 topography 
variables, NA, PA).  For these analyses, the dependent variables of interest were 




covariates. There were no significant within-subjects effects of any of the potential 
covariates on any of the dependent variables (all p’s >.05).  As such, we did not 
include any of the demographic variables as covariates in subsequent analyses. 
However, for theoretical reasons, in order to ensure that group (High vs. Average SP) 
differences in CPSD were not driving associations between SP, condition, and 
outcome (PA, NA, topography), we included CPSD as a covariate in all subsequent 
analyses. 
Primary Study Aim 1: To examine the relationship between level of SP (high 
SP, average SP) and cigarette smoking-related outcomes (smoking 
topography) as a function of condition (neutral, stress). 
To address the first primary study aim to determine whether smoking 
outcomes differed between conditions based on SP level, one 2x2 mixed factorial 
repeated measures ANOVA covarying for CPSD was conducted for each topography 
variable of interest (average puff volume, total puff volume, number of puffs, 
interpuff interval) with smoking outcomes as the dependent variable, condition (2; 
neutral, social stress) as the within-subject variable, and SP level (2; high SP, average 
SP) as the between-subjects variable resulting in four total repeated measures 
ANOVAs. These analyses revealed no significant between- or within-subjects 




Primary Study Aim 2: To examine the relationship between level of SP and 
NA as a function of condition. 
To address this study aim, we conducted two 3x2x2 repeated measures 
ANOVAs: one with NA as the dependent variable and one with PA as the dependent 
variable. We examined both NA and PA as dependent variables to determine 
whether: 1) there was a relationship between SP level, NA, and condition, and 2) if 
this relationship exists, whether it is specific to NA or consistent across both NA and 
PA regulation.  
To facilitate presentation of results, changes in NA and PA presented below 
are referred to across three time points: post cigarette 1, pre cigarette 2, and post 
cigarette 2.  For the neutral session, post cigarette 1 refers to the time period 
following smoking the first cigarette of the session and before watching the nature 
video, pre cigarette 2 refers to the time period between watching the nature video and 
smoking the second cigarette of the session, and post cigarette 2 refers to the period 
following smoking the second cigarette of the session. For the social stress session, 
post cigarette 1 refers to the time period following smoking the first cigarette of the 
session and before watching the Trier social stress video, pre cigarette 2 refers to the 
time following watching the Trier video while participants anticipated that they 
would be giving a speech to a panel of judges, but before smoking the second 
cigarette, and post cigarette 2 refers to the period following smoking the second 





NA Omnibus Repeated Measures ANOVA. To address the second primary 
study aim, a 3x2x2 mixed factorial repeated measures ANOVA was conducted. NA 
was the dependent variable, PANAS administration (3; post cigarette 1, pre cigarette 
2, post cigarette 2) and condition (2; neutral, social stress) were the within-subjects 
variables, and SP level (2; high SP, average SP) was the between-subjects variable. 
CPSD was entered as a covariate. Beyond a significant main effect of SP status [(F(1, 
66)=5.00, p =.03], results indicated a significant three-way interaction of condition, 
time (PANAS administration), and SP status [(F(2, 66) = 5.33, p = .006]. This 
interaction was probed separately for the neutral and stress conditions.  
Neutral session. During the neutral session, there were no significant between- 
or within-subjects effects of SP group on NA. For a graphical depiction of the 
relationship between SP group and NA during the neutral session, see Figure ii 
below. 
Social stress session. For ease of presentation, between- and within-subjects 
effects of SP group on NA during the social stress session are described separately 
below. See Figure iii below for a graphical depiction of the between- and within-
subjects effects.  
Between-subjects effects. In the social stress session, the SP groups differed at 
pre cigarette 2 and post cigarette 2. Specifically, High SP individuals reported 
significantly more NA [(F(1, 67)=6.73, p=.01] than Average SP individuals at pre 
cigarette 2. These group differences held following smoking the second cigarette in 
the social stress session such that High SP individuals reported significantly more NA 




Within-subjects effects. In the social stress session, NA significantly changed 
over time indicated by significant within-subjects effects of SP group on NA from 
post cigarette 1 to pre cigarette 2 [(F(1, 67)=4.93, p=.03] and from pre cigarette 2 to 
post cigarette 2 [(F(1, 67)=4.22, p=.04]. To understand the nature of these effects, we 
further probed the interaction by running two separate repeated measures ANOVAs: 
one for the high SP group and one for the average SP group. For high SP individuals, 
NA significantly increased from post cigarette 1 to pre cigarette 2 [F(1,28)=6.59, 
p=.02] and then significantly decreased from pre cigarette 2 to post cigarette 2 
[F(1,28)=4.35, p=.05]. The average SP group did not significantly change in level of 
NA during the social stress session. 
PA Omnibus Repeated Measures ANOVA. Second, to determine whether the 
interaction between SP group and condition was unique to NA or consistent across 
both NA and PA regulation, a second 3x2x2 mixed factorial repeated measures 
ANOVA was conducted. PA was the dependent variable, PANAS administration (3; 
post cigarette 1, pre cigarette 2, post cigarette 2) and condition (2; neutral, social 
stress) were the within-subjects variables, and SP level (2; high SP, average SP) was 
the between-subjects variable. CPSD was entered as a covariate. Results indicated a 
significant three-way interaction of condition, time (PANAS administration), and SP 
status [(F(2, 66)=3.45, p=.04]. The main effect of SP status on PA was not significant 
[(F(1, 66)=2.81, p=.10].  This interaction was probed separately for the neutral and 
stress conditions. 
To explore the nature of this within-subjects effect, similar to the previous 




ANOVAs (one per condition). For these analyses, PA was the dependent variable, 
PANAS administration (3; post cigarette 1, pre cigarette 2, post cigarette 2) was the 
within-subject variable, and SP level (2; high SP, average SP) was the between-
subjects variable. CPSD was entered as a covariate. Results are described by session 
below.  
Neutral session. During the neutral session, there were no significant within-
subjects effects of SP group on PA. For a graphical depiction of the effect of the 
relationship between SP group and PA during the neutral session, see Figure iv 
below. 
Social stress session. Despite the significant within-subjects effect in the 
omnibus test, there were no significant within-subjects effects of SP group on PA 
during the social stress session or during the neutral session. For a graphical 




Chapter 4: Discussion 
Summary of Main Findings 
The present study provided an experimental examination of the relationship 
between SP, social stress, cigarette smoking, and affect in order to understand the 
functional role of cigarette smoking for individuals with SP symptomatology. 
Previous epidemiological studies have suggested that there is a temporal relationship 
between SP and cigarette smoking such that SP precedes the onset of cigarette 
smoking (Breslau, Novak, Kessler, 2004; Johnson et al., 2000; Sonntag et al., 2004). 
Not only does SP represent a risk factor for the initiation of cigarette smoking, but 
individuals with SP also have more difficulty quitting smoking than individuals 
without a psychological comorbidity (Lasser et al., 2000). Thus, SP appears to be a 
unique risk factor for both the initiation and maintenance of cigarette smoking over 
time. Towards developing targeted prevention and cessation interventions for this 
high risk group, it is important to understand the functional role of cigarette smoking 
for individuals with SP. The present study attempted to fill this gap in this literature. 
The first primary study aim was to examine group differences (high SP, 
average SP) in smoking behavior in response to two conditions (neutral, induced 
social stress) among individuals who smoke cigarettes. Consistent with literature 
among non-socially phobic smokers suggesting that cigarettes may be used as an 
anxiolytic when experiencing stress (Kassel & Unrod, 2000), we hypothesized that 
high SP participants would exhibit significantly higher smoking topography indices 




average SP participants in anticipation of a socially stressful situation (giving a 
speech to a panel of judges). This hypothesis was not supported. High and average SP 
individuals did not significantly differ in any smoking topography variables in 
anticipation of the social stressor. There are two plausible explanations for this 
finding. First, for the present study, we were interested in individuals between the 
ages of 18 and 21 and recruited a sample consisting of relatively light smokers with 
low levels of nicotine dependence. Because this was true of both groups, there might 
not have been enough variability in topography in anticipation of the stressor due to 
low levels of smoking and nicotine dependence among all participants. A second 
explanation for this finding is that the function of cigarette smoking among high SP 
individuals when experiencing social stress is to regulate NA and affect regulation 
operates independently from amount of nicotine consumed.  
With the second primary study aim, we addressed the possibility of the 
relationship between SP and cigarette smoking being driven by affect regulation, 
which may operate independently from amount of nicotine consumed. Specifically, 
utilizing a negative reinforcement framework, we hypothesized that for high SP 
individuals, anticipation of a social stressor would significantly increase NA, while 
smoking a cigarette while still anticipating a social stressor would significantly 
decrease NA. We hypothesized that this effect would be unique to the high SP group 
in the social stress condition and would also be specific to NA. This hypothesis was 
supported. High SP individuals reported significant increases in NA when told they 
would have to give a speech to a panel of judges who would judge their performance. 




group reported significantly decreased NA from the prior time point. Average SP 
individuals did not report significantly higher NA in anticipation of the social stressor 
and did not report significant decreases in NA after smoking a cigarette. Further, this 
effect was specific to NA and was not observed when examining changes in PA. 
Taken together with results from the first study aim, this suggests that while high SP 
individuals do not change their smoking behavior when experiencing social stress, 
cigarette smoking helps to significantly reduce NA while experiencing social stress. 
Thus, NA regulation when experiencing social stress may be one factor that maintains 
cigarette smoking in individuals with SP or with elevated SP symptoms.  
Results from primary study aims one and two extend the work of Perkins and 
colleagues (2010) who found that NA relief following cigarette smoking was not 
dependent on the nicotine content of a cigarette, but rather on the type of NA mood 
induction used and the measure used for assessing changes in affect. One of the mood 
induction paradigms used by Perkins and colleagues (2010) was similar to the social 
stress mood induction used in the present study in that participants were required to 
deliver two speeches to panels of judges. Perkins and colleagues (2010) found that 
during this mood induction, smoking attenuated NA as measured by the PANAS, but 
not on other measures of NA. The present study extends the findings of Perkins and 
colleagues (2010) to a high risk group of smokers, smokers with elevated symptoms 
of SP, in a mood induction paradigm specifically targeted toward the situation in 
which these smokers might smoke to relieve NA. As suggested by Perkins and 
colleagues (2010), the effects of smoking, especially in regards to NA, may not be 




responses and the reinforcement of these conditioned responses over time. With the 
results of the present study in mind, this conditioned response pattern may be critical 
for smokers with elevated SP symptoms in the context of social stress and may be key 
to the development of efficacious smoking prevention and smoking cessation 
interventions for this high risk group.  
While NA regulation through cigarette smoking may be of great importance 
for individuals with SP in the context of social stress, there is reason to believe that 
this relationship is not unique to individuals with SP who are experiencing social 
stress, but rather may be a broader factor that serves to maintain tobacco use in 
smokers more broadly. Indeed, there is much support across the smoking literature for 
the role of negative affect regulation in maintaining cigarette use among smokers 
(Baker, Brandon, & Chassin, 2004; Brandon, 1994). This relationship may be 
uniquely important for smokers with threshold and subthreshold psychopathology, 
and has found support among a number of disorders including depression 
(Weinberger, George, & McKee, 2011), generalized anxiety disorder (Moylan, Jacka, 
Pasco, & Berk, 2013), panic disorder (Mitchell et al., 2012), and ADHD (McClernon 
& Kollins, 2008). As such, while many cessation programs for smokers with 
psychopathology have focused on disorder-specific treatments (i.e., Brown et al., 
2001; MacPherson et al., 2010; Winhusen et al., 2010) a transdiagnostic approach 
specifically targeting the relationship between NA regulation and continued tobacco 
use may afford the greatest degree of applicability for smokers attempting to quit. For 
example, strategies from MacPherson and colleagues’ Behavioral Activation 




through reductions in negative affect and increases in positive affect, may be useful in 
moving towards transdiagnostic cessation programs. 
Limitations 
Results from the present study should be interpreted with the following 
limitations in mind. First, participants in the study were relatively light smokers with 
low levels of nicotine dependence. They were also all undergraduate students 
between the ages of 18 and 21. It is unclear how these findings might generalize to 
heavier, more dependent smokers, or smokers of different ages. Additionally, it is 
unclear the extent to which the smoking characteristics of this group influenced 
participants’ decisions to smoke the second cigarette in each experimental session. It 
is possible that the relatively low levels of smoking among this sample contributed to 
some of the participants choosing not to smoke the second cigarette in the 
experimental sessions. Second, we used a validated SP measure for categorizing our 
SP groups. While the cutoffs we used have been validated in previous studies to 
distinguish between individuals with and without SP (Mattick & Clark, 1998), we did 
not use a diagnostic interview in the present study so we cannot be certain that all 
individuals in our high SP would meet diagnostic criteria for SP. Third, participants 
smoked cigarettes of their own brand during experimental sessions. As such, we were 
unable to standardize cigarette nicotine content across participants. We made this 
experimental decision in order to mimic naturalistic smoking behavior. However, it is 
possible that there could have been group differences by condition in the amount of 
nicotine self-administered when given the option to smoke due to differences in 





There are a number of important future directions from this line of research 
which cluster around both experimental future directions as well as future prevention 
and cessation interventions. Regarding experimental next steps, there are a number of 
important candidate moderators which may help to better understand the relationship 
between SP, cigarette smoking, and negative affect regulation which we were unable 
to explore in the present study. Candidate moderators include gender, nicotine 
dependence, age, severity of SP symptoms, and nature of SP symptoms (i.e., social 
interaction anxiety vs. social performance anxiety and generalized vs. non-
generalized SP). Additionally, to further explore the relationship between the 
pharmacologic effects of nicotine on NA and reinforcement-based learning on NA, 
future experimental studies could experimentally manipulate the nicotine content of 
cigarettes (using high vs. low yield nicotine containing cigarettes, for instance) to 
further disentangle this relationship. Third, in the present study, a small subset of the 
sample opted to not smoke the second cigarette during the experimental sessions. In 
order to capture smoking behavior of lower level smokers such as college-aged 
smokers, it will be important for future studies to consider how best to mimic 
naturalistic smoking patterns in the context of experimental design. Regarding 
prevention, the present study suggests that smoking may be maintained among 
socially phobic smokers due to NA regulation in the context of social stress 
associated with cigarette smoking. Keeping in mind that the onset of SP tends to 
precede the onset of cigarette smoking, preventative interventions incorporating NA 




with elevated symptoms of SP in order to decrease the likelihood of smoking 
initiation. Evidence-based treatments that have found empirical support for 
decreasing negative affect and, in turn, increasing positive affect (for example, 
Behavioral Activation) may be the best fits as preventative interventions for 
addressing this NA risk factor. Second, because socially phobic smokers have less 
success with quitting smoking than individuals without psychological comorbidity, 
NA regulation strategies specifically addressing social situations may be especially 
important for improving cessation rates among smokers with SP or with elevated SP 
symptoms. Evidenced-based strategies such as exposure therapy may be relevant here 
to demonstrate natural reductions in NA over time when not given the option to 
smoke a cigarette following social situations. 
Conclusions 
Cigarette smoking remains a major public health concern and the prevalence 
of smoking is higher and cessation rates are lower among individuals with SP when 
compared to individuals without psychological comorbidities. In order to create 
efficacious prevention and intervention programs for this high risk group, it is 
necessary to understand the functional role of cigarette smoking for socially phobic 
individuals. The present study is the first to our knowledge to experimentally examine 
the functional relationship between SP, cigarette smoking, and social stress and 
implicates the role of NA regulation in the context of social stress as a cigarette 
smoking maintaining factor for individuals with SP. While individuals high in SP did 
not smoke differently in the context of social stress as compared to a neutral condition 




experiencing social stress, high SP individuals experienced significantly reduced NA. 
This negative affect reduction fits within existing negative reinforcement frameworks 
for the maintenance of cigarette smoking and extends this framework to a specific 
high risk group in the context of a high risk situation. Incorporating NA regulatory 
strategies for socially stressful situations may help to both prevent smoking initiation 
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Table ii. Sample demographics 
 











Age M(SD) 19.75(1.18) 19.94(1.21) 19.61(1.16) 
Gender (% female) 41.7% 45.2% 39.0% 
Racial/ethnic background    
     White  73.6% 71.0% 75.6% 
     Black or African American 6.9% 9.7% 4.9% 
     Asian or Asian American 15.3% 12.9% 17.1% 
     Hispanic or Latino 2.8% 3.2% 2.4% 
     Other  1.8% 3.2% 0% 
Cigarettes per smoking day 
M(SD)* 





Table iii. Number of participants who chose to smoke each cigarette




 First Cigarette Second 
Cigarette 





















Table iv. Smoking topography data 






Neutral Session    
Cigarette 1 M(SD) n = 69  n = 30 n = 39 
   Number of puffs  16.29(5.77) 16.67(5.25) 16.00(6.19) 
   Puff volume (ml) 46.05(22.04) 45.22(23.86) 46.68(20.83) 
   Total puff volume (ml) 699.45(340.09) 734.43(421.28) 672.54(264.23) 
   Interpuff Interval (s) 13.76(5.66) 12.86(5.68) 14.44(5.61) 
Cigarette 2 M(SD) n = 63 n = 30 n = 33 
   Number of puffs  15.94(6.12) 16.57(5.91) 15.36(6.34) 
   Puff volume (ml) 42.21(19.03) 41.86(21.66) 42.53(16.62) 
   Total puff volume (ml) 642.73(334.12) 689.59(425.77) 600.13(219.26) 
   Interpuff Interval (s) 14.41(8.32) 13.60(6.61) 15.15(9.67) 
Stress Session    
Cigarette 1 M(SD) n = 66 n = 28 n = 38 
   Number of puffs  15.89(5.65) 15.57(5.78) 16.13(5.62) 
   Puff volume (ml) 46.75(29.98) 39.82(13.18) 51.86(37.28) 
   Total puff volume (ml) 748.23(697.29) 632.99(332.16) 833.15(869.59) 
   Interpuff Interval (s) 14.38(6.68) 13.79(6.08) 14.81(7.14) 
Cigarette 2 M(SD) n = 60 n = 26 n = 34 
   Number of puffs  15.22(5.24) 15.65(5.81) 14.88(4.82) 
   Puff volume (ml) 45.86(29.67) 46.77(40.95) 45.17(17.40) 
   Total puff volume (ml) 652.46(337.46) 668.65(415.63) 640.08(269.01) 




Table v. Positive and negative affect data 
 
Note. Post cigarette 1: Affect ratings following smoking the first cigarette at each 
session. Pre cigarette 2: Affect ratings following being administered the Trier variant 
or watching the neutral video. Post cigarette 2: Affect ratings following smoking the 
second cigarette at each session.  






Neutral Session    
Post Cigarette 1 M(SD)    
     Positive Affect   26.24(7.62) 25.17(6.51) 27.02(8.33) 
     Negative Affect 14.27(4.99) 14.83(3.92) 13.85(5.65) 
Pre Cigarette 2 M(SD)    
     Positive Affect 24.67(8.07) 24.20(7.24) 25.02(8.70) 
     Negative Affect  12.11(3.81) 11.97(2.43) 12.22(4.59) 
Post Cigarette 2 M(SD)    
     Positive Affect 24.97(8.90) 24.00(9.44) 25.71(8.51) 
     Negative Affect  12.51(3.38) 12.90(2.41) 12.22(3.96) 
Stress Session    
Post Cigarette 1 M(SD)    
     Positive Affect   25.77(6.86) 24.58(6.26) 26.63(7.22) 
     Negative Affect 14.55(5.46) 15.40(5.20) 13.93(5.62) 
Pre Cigarette 2 M(SD)    
     Positive Affect 26.34(8.49) 23.07(7.98) 28.73(8.13) 
     Negative Affect  19.25(7.16) 22.60(8.16) 16.80(5.19) 
Post Cigarette 2 M(SD)    
     Positive Affect 26.62(8.95) 23.77(8.20) 28.71(9.00) 
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Figure iii: The relationship between SP group and NA during the social stress session. 
There were significant between-subjects effects of SP group on NA such that High SP 
individuals were significantly higher in NA at pre cigarette 2 and post cigarette 2. 
There were also significant within-subjects effects such that High SP significantly 
increased in NA in anticipation of the social stressor and significantly decreased in 
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